OncoTherapy Science, Inc.JP:4564
| Mar 31,
2013 | Mar 31,
2014 | Mar 31,
2015 | Mar 31,
2016 | Mar 31,
2017 | Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2023 | Mar 31,
2024 |
|---|
| Profit (loss) before income taxes | -1,129 | -3,716 | -1,362 | -2,789 | -2,998 | -2,919 | -3,195 | -2,237 | -1,560 | -2,570 | -1,116 | -1,286 |
|---|
| Impairment losses | - | - | - | - | - | - | 319 | 166 | 11 | 548 | 22 | 155 |
|---|
| Interest expenses | - | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Share-based payment expenses | 183 | 87 | 10 | - | - | - | - | - | - | 39 | 31 | 8 |
|---|
| Share issuance costs | - | - | - | - | - | - | - | - | - | - | - | 10 |
|---|
| Gain on sale of non-current assets | - | - | - | - | - | - | - | -50 | -0 | -0 | -0 | - |
|---|
| Gain on reversal of share acquisition rights | - | -52 | -317 | -174 | -11 | -58 | -83 | -87 | -90 | -49 | -38 | -5 |
|---|
| Decrease (increase) in trade receivables | 1,444 | 1,323 | 22 | 12 | -2 | 1 | -17 | -12 | -123 | -247 | 277 | 87 |
|---|
| Decrease (increase) in inventories | -3 | -0 | 4 | 6 | 3 | -2 | -11 | 0 | -16 | -190 | 131 | 26 |
|---|
| Decrease (increase) in advance payments to suppliers | -472 | 701 | 25 | -26 | -14 | -4 | 73 | 8 | -11 | -5 | 3 | 7 |
|---|
| Decrease (increase) in consumption taxes refund receivable | - | - | - | - | 20 | -55 | 33 | 15 | 15 | -26 | 45 | -36 |
|---|
| Increase (decrease) in accounts payable - other | -16 | 2 | -126 | 39 | 65 | -48 | -16 | -97 | 34 | 252 | -173 | -92 |
|---|
| Income taxes refund | - | 348 | 59 | 2 | - | - | - | - | - | - | - | -67 |
|---|
| Increase (decrease) in contract liabilities | - | - | - | - | - | - | - | - | - | 22 | 124 | 51 |
|---|
| Increase (decrease) in income taxes payable - factor based tax | - | - | - | - | 22 | -50 | 103 | -31 | -74 | 134 | -67 | -67 |
|---|
| Relocation expenses | - | - | - | - | - | - | - | - | - | - | 16 | - |
|---|
| Other, net | -221 | -1 | 72 | -84 | -35 | -46 | 33 | 13 | 5 | 6 | -30 | -16 |
|---|
| Subtotal | 262 | -1,996 | -1,767 | -2,890 | -2,985 | -3,033 | -2,369 | -2,273 | -1,760 | -2,071 | -776 | -1,225 |
|---|
| Interest paid | - | - | - | - | - | - | - | - | - | - | - | -0 |
|---|
| Income taxes paid | -717 | -2 | -4 | -20 | -4 | -5 | -5 | -3 | -3 | -3 | -3 | -3 |
|---|
| Payments of relocation expenses | - | - | - | - | - | - | - | - | - | - | -16 | - |
|---|
| Net cash provided by (used in) operating activities | -456 | -1,650 | -1,703 | -2,898 | -2,988 | -3,036 | -2,373 | -2,276 | -1,763 | -2,073 | -795 | -1,228 |
|---|
| Purchase of property, plant and equipment | -30 | -20 | -46 | -112 | -11 | -409 | -71 | -131 | -44 | -457 | -5 | -3 |
|---|
| Proceeds from sale of property, plant and equipment | - | 0 | - | - | - | - | - | 103 | 0 | 0 | 0 | - |
|---|
| Payments for asset retirement obligations | - | - | - | - | - | - | - | - | - | - | -11 | -70 |
|---|
| Payments of leasehold and guarantee deposits | - | - | - | - | - | - | - | - | - | -10 | -5 | - |
|---|
| Proceeds from refund of leasehold and guarantee deposits | - | - | - | - | - | - | - | - | - | - | 1 | 40 |
|---|
| Net cash provided by (used in) investing activities | -10 | -13,041 | 1,884 | 10,883 | -12 | -446 | -74 | -31 | -52 | -468 | -20 | -33 |
|---|
| Repayments of long-term accounts payable - other | - | - | - | - | - | - | - | - | - | - | - | -5 |
|---|
| Proceeds from deposits received | - | - | - | - | - | - | - | - | - | - | 96 | - |
|---|
| Proceeds from issuance of shares | 25 | 11,017 | 68 | 12 | 2 | 1 | 554 | 2,164 | - | 1,467 | - | 683 |
|---|
| Proceeds from issuance of share acquisition rights | - | - | - | - | - | - | 12 | - | - | 12 | - | -7 |
|---|
| Other, net | - | - | - | - | - | - | - | - | - | - | - | -0 |
|---|
| Net cash provided by (used in) financing activities | 25 | 11,017 | 68 | 12 | 2 | 151 | 566 | 2,164 | - | 1,479 | 96 | 671 |
|---|
| Net increase (decrease) in cash and cash equivalents | -440 | -3,672 | 247 | 7,998 | -2,997 | -3,333 | -1,883 | -144 | -1,815 | -1,062 | -719 | -590 |
|---|